Claritev Corporation Reports Second Quarter 2026 Results
Claritev Corporation reports financial results for the second quarter ended June 30, 2026.
Q2 2026 Revenues of $257.5 million grew 6.6% compared to Q2 2025
Net Loss of $59.2 million
Adjusted EBITDA of $155.8 million increased 1.1% compared to Q2 2025 (Adjusted EBITDA Margin of 60.5% versus 63.8% in Q2 2025)
MCLEAN, VA — August 7, 2026 — Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the second quarter ended June 30, 2026.
Recent news
-
Claritev Corporation Announces Participation in Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Read More -
Claritev Introduces Transparency-Based Pricing, Turning Complex Public Market Data into Actionable Reimbursement Intelligence
Read More -
Claritev Appoints Jennifer Main to its Board of Directors
Read More